Mission Wealth Management LP lifted its holdings in shares of The Procter & Gamble Company (NYSE:PG – Free Report) by 2.0% in the fourth quarter, Holdings Channel.com reports. The fund owned 45,608 shares of the company’s stock after purchasing an additional 873 shares during the quarter. Mission Wealth Management LP’s holdings in Procter & Gamble were worth $6,683,000 at the end of the most recent reporting period.
Other institutional investors have also recently added to or reduced their stakes in the company. Wyrmwood Management LLC acquired a new position in Procter & Gamble during the fourth quarter worth $29,000. Naples Money Management LLC acquired a new position in shares of Procter & Gamble in the fourth quarter valued at $29,000. Criterion Capital Advisors LLC acquired a new position in shares of Procter & Gamble in the fourth quarter valued at $33,000. Mendota Financial Group LLC increased its holdings in shares of Procter & Gamble by 636.6% in the fourth quarter. Mendota Financial Group LLC now owns 302 shares of the company’s stock valued at $44,000 after purchasing an additional 261 shares during the last quarter. Finally, Morton Brown Family Wealth LLC increased its holdings in shares of Procter & Gamble by 206.6% in the fourth quarter. Morton Brown Family Wealth LLC now owns 417 shares of the company’s stock valued at $61,000 after purchasing an additional 281 shares during the last quarter. 65.77% of the stock is owned by institutional investors.
Procter & Gamble Price Performance
Shares of PG stock traded up $1.54 on Tuesday, reaching $163.20. The company had a trading volume of 8,105,405 shares, compared to its average volume of 6,942,727. The stock has a market capitalization of $385.17 billion, a PE ratio of 26.52, a price-to-earnings-growth ratio of 3.27 and a beta of 0.44. The company has a quick ratio of 0.48, a current ratio of 0.69 and a debt-to-equity ratio of 0.49. The Procter & Gamble Company has a one year low of $141.45 and a one year high of $164.32. The business’s 50-day moving average is $159.72 and its 200 day moving average is $153.78.
Procter & Gamble Increases Dividend
The company also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Friday, April 19th will be given a dividend of $1.0065 per share. This represents a $4.03 dividend on an annualized basis and a yield of 2.47%. The ex-dividend date is Thursday, April 18th. This is an increase from Procter & Gamble’s previous quarterly dividend of $0.94. Procter & Gamble’s dividend payout ratio is currently 65.85%.
Insider Transactions at Procter & Gamble
In other Procter & Gamble news, CEO R. Alexandra Keith sold 776 shares of the firm’s stock in a transaction on Monday, March 4th. The stock was sold at an average price of $158.11, for a total transaction of $122,693.36. Following the transaction, the chief executive officer now directly owns 4,859 shares in the company, valued at approximately $768,256.49. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. In other news, CEO R. Alexandra Keith sold 776 shares of the stock in a transaction on Monday, March 4th. The stock was sold at an average price of $158.11, for a total value of $122,693.36. Following the sale, the chief executive officer now directly owns 4,859 shares of the company’s stock, valued at $768,256.49. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider Susan Street Whaley sold 3,865 shares of the stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $160.60, for a total value of $620,719.00. Following the completion of the sale, the insider now owns 11,886 shares of the company’s stock, valued at approximately $1,908,891.60. The disclosure for this sale can be found here. Insiders sold a total of 55,865 shares of company stock valued at $9,009,280 in the last quarter. 0.17% of the stock is currently owned by company insiders.
Wall Street Analysts Forecast Growth
Several equities analysts have commented on the stock. UBS Group upped their price objective on shares of Procter & Gamble from $172.00 to $178.00 and gave the company a “buy” rating in a report on Wednesday, January 24th. The Goldman Sachs Group initiated coverage on shares of Procter & Gamble in a report on Friday, March 1st. They issued a “neutral” rating and a $168.00 price objective on the stock. JPMorgan Chase & Co. decreased their price target on shares of Procter & Gamble from $169.00 to $162.00 and set an “overweight” rating on the stock in a research note on Thursday, January 18th. Royal Bank of Canada upped their price target on shares of Procter & Gamble from $156.00 to $157.00 and gave the company a “sector perform” rating in a research note on Wednesday, January 24th. Finally, Jefferies Financial Group upped their price target on shares of Procter & Gamble from $175.00 to $182.00 and gave the company a “buy” rating in a research note on Monday, April 22nd. Seven analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $169.76.
About Procter & Gamble
The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.
Further Reading
- Five stocks we like better than Procter & Gamble
- There Are Different Types of Stock To Invest In
- NXP Semiconductors Will Set a New High Soon: $300 in Sight
- Stock Market Upgrades: What Are They?
- Hilton Demonstrates Asset Light is Right for Investors
- What Are Dividend Champions? How to Invest in the Champions
- Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.